Buy Draxxin KP (Tulathromycin & Ketoprofen) Injectable Solution Online: The Definitive Veterinary Guide to Dual-Action Triamilide & NSAID Synergy, BRD Fever Control, and Subcutaneous Pulmonary Therapy in Beef and Non-Lactating Dairy Cattle

Managing Bovine Respiratory Disease (BRD) complex in beef cattle, feedlot stockers, and dairy replacement heifers requires a rapid, comprehensive treatment strategy. When environmental stress weakened the calf’s mucosal defenses, opportunistic bacterial pathogens rapidly colonize the lower respiratory tract. This bacterial proliferation triggers a severe systemic inflammatory response, leading to high fever ($104^circtext{F}$ to $107^circtext{F}$), intense lung tissue damage, excessive exudate accumulation, and painful, labored breathing.

When a calf suffers simultaneously from a high fever and an active bacterial lung infection, appetite drops sharply. The animal stops eating, becomes severely lethargic, and quickly succumbs to permanent pulmonary lesions or fatal pneumonia if therapeutic intervention is delayed.

Treating the underlying bacterial infection alone with a single-agent antibiotic often leaves the animal suffering from persistent fever and inflammatory tissue damage for 24 to 48 hours, delaying feed intake recovery and increasing permanent lung scarring.

To knock down high fever rapidly while clearing bacterial pathogens in a single step, livestock veterinarians rely on combination therapies. Draxxin KP Injectable Solution (manufactured by Zoetis) is a premier, dual-action prescription therapy approved for the treatment of BRD and BRD-associated fever. Combining a broad-spectrum, long-acting macrolide (Tulathromycin) with a fast-acting non-steroidal anti-inflammatory drug (Ketoprofen), Draxxin KP controls both the bacterial infection and the inflammatory fever in a single subcutaneous injection.

This comprehensive clinical manual covers the dual-action pharmacology, tissue distribution kinetics, target pathogen spectrum, and precise administration protocols for Draxxin KP.

Dual-Action Pharmacology & Inflammatory Cascade Suppression

Draxxin KP delivers a synchronized, two-pronged therapeutic attack that targets both bacterial cell machinery and the host’s inflammatory fever pathway:

                          [Draxxin KP Injection Administered]
                                          |
                      [Subcutaneous Neck Injection & Depot Uptake]
                                          |
                 -------------------------------------------------
                |                                                 |
       [ANTIMICROBIAL ATTACK]                           [ANTI-INFLAMMATORY SHIELD]
       (Tulathromycin 100mg/mL)                           (Ketoprofen 120mg/mL)
                |                                                 |
                v                                                 v
     [Binds 50S Ribosomal Subunit]                    [Inhibits Cyclooxygenase Pathways]
     (Halts Bacterial Protein Synthesis)              (Suppresses Prostaglandin Synthesis)
                |                                                 |
                v                                                 v
     [Sustained Lung Tissue Depot]                    [Rapid Fever Reduction within Hours]
     (Protects Lungs for up to 14 Days)               (Restores Appetite & Bunk Visits)
                |                                                 |
                 ------------------------> <----------------------
                                        |
                                        v
                    [Rapid Resolution of Clinical BRD & Pyrexia]
                                        |
                    [Maximized Recovery with Minimal Animal Handling]

Protein Synthesis Inhibition via Tulathromycin

Tulathromycin ($100 text{mg/mL}$) is a semi-synthetic triamilide macrolide. It acts by binding to the 50S subunit of susceptible bacterial ribosomes, preventing the transpeptidation and translocation steps required for protein chain elongation. Tulathromycin rapidly concentrates in pulmonary epithelial lining fluid and alveolar macrophages, providing sustained antibacterial coverage in lung tissue for up to 14 days.

Rapid Fever Reduction via Ketoprofen

Ketoprofen ($120 text{mg/mL}$) is a potent propionic acid derivative belonging to the non-steroidal anti-inflammatory drug (NSAID) class:

• Cyclooxygenase Inhibition: Ketoprofen inhibits cyclooxygenase (COX) enzymes, blocking the conversion of arachidonic acid into pro-inflammatory prostaglandins ($PGE_2$) that drive systemic fever and localized tissue pain.

• Rapid Anti-Pyretic Action: Clinical studies demonstrate that the ketoprofen component in Draxxin KP produces a rapid drop in BRD-associated fever within hours of administration, encouraging sick calves to return to feed bunks and stay hydrated.

Target Pathogen Spectrum

Draxxin KP provides broad-spectrum antibacterial coverage against the primary bacterial drivers of Bovine Respiratory Disease:

• Mannheimia haemolytica

• Pasteurella multocida

• Histophilus somni

• Mycoplasma bovis

Core Livestock Clinical Indications

Draxxin KP is a foundational therapeutic tool across beef cattle operations, stocker facilities, and dairy replacement heifer programs:

• Treatment of BRD with Associated Fever: Indicated as a single-dose treatment for Bovine Respiratory Disease associated with M. haemolytica, P. multocida, H. somni, and M. bovis, and for the control of pyrexia (fever) associated with BRD.

• Rapid Appetite & Vitality Restoration: Used to quickly lower high body temperatures and relieve respiratory inflammation, minimizing weight loss and supporting normal growth rates during acute disease stress.

• Single-Dose Efficiency: Eliminates the need for separate injections of an antibiotic and an NSAID, reducing animal handling stress and labor costs.

Recommended Administration and Dosing Protocols

To ensure optimal therapeutic absorption and preserve food safety standards, Draxxin KP must be administered strictly according to weight-based guidelines.

Livestock Dosage Reference Table

The table below outlines standard clinical dosing parameters for Draxxin KP Injectable Solution:

Clinical Safety, Regulatory Compliance, and Storage

• Lactating Dairy Cattle Restrictions: Do not use Draxxin KP in female dairy cattle 20 months of age or older, as milk residue parameters have not been established for lactating dairy cows. Do not use in calves to be processed for veal.

• Subcutaneous Route Requirement: Draxxin KP is formulated strictly for Subcutaneous (SQ) injection in the neck. Do not inject intramuscularly or intravenously.

• Mandatory Slaughter Withdrawal Period: Animals treated with Draxxin KP must not be slaughtered for human consumption within 18 days of the last treatment.

• Injection Site Reactions: Transient localized swelling or firmness at the injection site may occur following subcutaneous administration. These local reactions typically resolve without intervention.

• Storage Parameters: Store at controlled room temperature between 20°C and 25°C (68°F to 77°F). Avoid direct sunlight exposure and protect from freezing. Use within 56 days of first puncture.

Frequently Asked Questions (FAQ)

What is the primary difference between standard Draxxin and Draxxin KP?

Standard Draxxin contains only the antibiotic tulathromycin. Draxxin KP combines tulathromycin with ketoprofen (a fast-acting NSAID), allowing it to clear BRD bacterial pathogens while simultaneously knocking down fever in a single injection.

How quickly does Draxxin KP reduce fever in cattle suffering from BRD?

The ketoprofen component in Draxxin KP acts rapidly, producing a significant reduction in BRD-associated fever within hours of administration.

Can Draxxin KP be given into the muscle (IM)?

No. Draxxin KP is approved strictly for Subcutaneous (SQ) injection in the neck. Intramuscular injection can alter drug depletion kinetics and cause muscle tissue damage.

Where can I buy genuine Draxxin KP online?

You can safely purchase authentic, factory-sealed Draxxin KP Injectable Solution online through World Equine Vet. We manage our full inventory under strict environmental controls to guarantee absolute product quality and full therapeutic potency.

Secure Premium Sourcing from World Equine Vet

At World Equine Vet, we understand that managing livestock health emergencies requires absolute product reliability. Every vial of Draxxin KP (Tulathromycin & Ketoprofen) Injectable Solution is sourced through authorized distribution channels, stored in our climate-controlled facility, and shipped securely to protect product stability.

For wholesale livestock accounts, feedlot supply orders, or logistics tracking assistance, please reach out to our professional support desk directly at our contact us page.